デジタル治療の世界市場：予防（糖尿病前症、肥満）、ケア（糖尿病、CVD、CNS、慢性呼吸器疾患、禁煙治療、筋骨格障害）...市場調査レポートについてご紹介

1 Introduction (Page No. – 18)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Market Stakeholders

2 Research Methodology (Page No. – 21)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Key Data From Secondary Sources
2.4 Key Data From Primary Sources
2.5 Key Industry Insights
2.6 Assumptions for the Study

3 Executive Summary (Page No. – 29)

4 Premium Insights (Page No. – 35)
4.1 Market Overview
4.2 Market, By Application
4.3 Market for Preventive Applications
4.4 Market for Treatment/Care Applications
4.5 Market, By Sales Channel
4.6 Market for B2C Sales Channel, By Buyer
4.7 Market for B2B Sales Channel, By Buyer
4.8 Market: Geographic Snapshot

5 Market Overview (Page No. – 41)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Incidence of Preventable Chronic Diseases
5.2.1.2 Rising Focus on Preventive Healthcare
5.2.1.3 Technological Advancements
5.2.1.4 Need to Control Healthcare Costs
5.2.1.5 Significant Increase in Venture Capital Investments
5.2.1.6 Benefits Offered By Digital Therapeutics
5.2.1.6.1 Ability to Induce Behavioral Change
5.2.1.6.2 Improved Drug Adherence
5.2.1.6.3 Patient Convenience and User-Friendliness
5.2.2 Restraints
5.2.2.1 Lack of Awareness and Access to Digital Therapeutics Programs in Developing Countries
5.2.2.2 Patient Data Privacy Concerns
5.2.2.3 Resistance From Traditional Healthcare Providers
5.2.3 Opportunities
5.2.3.1 Emerging Markets Offer Significant Growth Opportunities
5.2.3.2 Large Undiagnosed and Untreated Population
5.2.3.3 Unexplored Therapeutic Applications
5.2.4 Challenges
5.2.4.1 Unfavorable Payment Models
5.2.4.2 Stringent Regulatory Guidelines
5.2.4.3 Reluctance Among Patients to Adopt Digital Therapeutics

6 Industry Insights (Page No. – 52)
6.1 Introduction
6.2 Porter’s Five Forces Analysis
6.2.1 Threat of New Entrants
6.2.2 Bargaining Power of Suppliers
6.2.3 Bargaining Power of Buyers
6.2.4 Threat of Substitutes
6.2.5 Intensity of Competitive Rivalry
6.3 Regulatory Requirements
6.3.1 Emerging Regulatory Framework for Digital Therapeutics
6.3.2 Health Information Portability and Accountability Act (HIPAA)
6.4 Venture Capital Investments
6.5 Pipeline Products

7 Digital Therapeutics Market, By Sales Channel (Page No. – 60)
7.1 Introduction
7.2 B2C
7.2.1 Caregivers
7.2.2 Patients
7.3 B2B
7.3.1 Providers
7.3.2 Payers
7.3.3 Pharmaceutical Companies
7.3.4 Employers
7.3.5 Other Buyers

8 Digital Therapeutics Market, By Type of Application (Page No. – 81)
8.1 Introduction
8.2 Preventive Applications
8.2.1 Prediabetes
8.2.2 Obesity
8.3 Treatment/Care-Related Applications
8.3.1 Diabetes
8.3.2 Central Nervous System (CNS) Disorders
8.3.3 Chronic Respiratory Diseases (CRD)
8.3.4 Musculoskeletal Disorders
8.3.5 Cardiovascular Diseases
8.3.6 Smoking Cessation
8.3.7 Medication Adherence
8.3.8 Other Applications

9 Digital Therapeutics Market, By Region (Page No. – 110)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Spain
9.3.5 Rest of Europe (RoE)
9.4 Asia-Pacific (APAC)
9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. – 152)
10.1 Overview
10.2 Competitive Situations and Trends
10.2.1 Partnerships, Collaborations, and Agreements
10.2.2 Investments
10.2.3 New Product Launches
10.2.4 Other Strategies

11 Company Profiles (Page No. – 160)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Introduction
11.2 Proteus Digital Health, Inc.
11.3 Omada Health, Inc.
11.4 Welldoc, Inc.
11.5 Livongo Health
11.6 Noom Inc.
11.7 Ginger.Io, Inc.
11.8 Propeller Health
11.9 2morrow Inc.
11.10 Canary Health Inc.
11.11 Mango Health Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 176)
12.1 Insights From Industry Experts
12.2 Discussion Guide
12.3 Other Developments, By Company, 2013–2016
12.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.5 Introducing RT: Real-Time Market Intelligence
12.6 Available Customizations
12.7 Related Reports